To support an HTA assessment of a diagnostic device for use outside hospitals, we developed an economic assessment and submission dossier addressing GP collaboration, training, and pricing uncertainties.
Delivering
Excellence
We combine strategic, analytic and communications excellence to optimally demonstrate your product’s value throughout its lifecycle.
World-class
Expertise
Choosing Visible Analytics gives you access to world-class technical and strategic expertise, whatever your project.
Personal
Service
Our approach is based on partnership, scientific excellence and personal service – with our Directors closely involved in every project.
Building bridges from data to decisions
Optimising value throughout the product lifecycle
We can work with you from early modelling and value propositions, through evidence generation, statistical and real-world data analysis, economic modelling, health technology assessment submission and value communication.
We work with clients across Europe, North America and Asia-Pacific on global, regional and local-level projects.
Our systematic reviews are conducted in accordance with internationally recognised guidelines and meet the standards of HTA bodies. We have specialist expertise in evidence synthesis and provide resourceful, innovative solutions based on data availability and jurisdiction requirements.
Our statistical team are experts in the full range of analyses required to inform economic evaluations, as well as in evidence synthesis and design and analysis of clinical trials, observational studies and real-world evidence datasets. We can also advise on the strategic implications of different analytical approaches for HTA.
We are experts in modelling for every stage of your product’s life cycle, including early decision-making models, pricing models, cost-effectiveness and budget impact models, and interactive payer-facing modelling tools.
We can help identify the most robust real-world data for your needs and design studies to inform clinical strategy, enhance market access and support regulatory submissions.
Our first-class strategic, technical and communications expertise makes us outstanding partners for your HTA submissions.
We combine our deep understanding of payer evidence requirements with our communications expertise to develop materials that demonstrate value to payers, clinicians and decision-makers.
Case studies
We addressed the challenge of modelling the association between a longitudinal biomarker and overall survival to enhance outcome predictions in an oncology treatment trial.
Estimate the comparative effectiveness of new blood cancer treatment given complex evidence base: disconnected network of RCTs and multiple treatment combinations evaluated
We optimised a cost-effectiveness model that initially lacked resonance and failed to demonstrate cost-effectiveness.
We developed a comprehensive market access strategy to support HTA and reimbursement submissions for a product with a unique mode of action, whose benefits were only partially reflected in clinical trials.
We addressed the challenge of interval-censored time-to-event outcomes in indirect treatment comparisons (ITCs), where differing assessment schedules could introduce bias.
We estimated potential prices and planning evidence generation with limited early-phase clinical data by creating a flexible, user-friendly pricing model tool.
We addressed the challenge of estimating survival advantage for an innovative treatment with no European-standard comparator and high crossover in pivotal trial.
What our clients say
Very high-quality discussions and deliverables, building a fast trustworthy working relationship and always on time.
It hasn’t been an easy journey and your support and advice on both technical and strategic matters have been crucial to get to this point.”
News & insights
Join us for an engaging webinar to explore the transformative power of RWE in HTA and how it’s driving better healthcare decisions and patient outcomes.
The Visible Analytics team will be in Barcelona and looks forward to meeting you there.
Come meet us at our booth 1506 and join us at one of our sessions.
Visible Analytics will be co-hosting a live webinar with Ascenian to discuss how HTA methods and early value assessment can help companies prepare for evidence generation and early market access strategy.
